| HOME >> MEDICINE >> TECHNOLOGY |
Six Months ResultsFor the six months period in 2011, PLC reported revenues of $455,000, compared to $516,000 in the same period of 2010. Net loss from continuing operations for the first six months of 2011 was $5,560,000, or a loss of $0.18 per basic and diluted share, compared to a net loss from continuing operations of $2,088,000, or a loss of $0.07 per share, in the same period last year.
Recent EventsKaren Raus, Controller and Principal Financial Officer of PLC, is leaving the company effective today for a CFO position at another company. The company has launched a search for a new principal financial officer.
Effective August 15, 2011, PLC is moving to a new, smaller facility, in Milford, Massachusetts, recognizing its lower space requirements and saving significant costs over the long-term.
About PLC Systems Inc.PLC Systems Inc., headquartered in Franklin, Mass., is a medical device company focused on innovative technologies for the cardiac and vascular markets. PLC's newest product, RenalGuard, has been developed to help prevent the onset of Contrast-Induced Nephropathy (CIN) in at-risk patients undergoing certain imaging procedures. The Product is CE-marked and is being marketed in Europe and selected countries around the world. Two investigator-sponsored European studies have demonstrated RenalGuard's effectiveness at preventing CIN. RenalGuard is being studied in a pivotal trial in the U.S., as required for approval by FDA.
This press release contains "forward-looking" statements. For this purpose, any statements contained in this press release that relate to prospective events or developments are deemed to be forward-looking statements. Words such as "believes," "anticipates," "plans," "expects," "will" and similar expressions are intended to identify forward-looking statements. Our statements of our objectives are also forward-looking s
'/>"/>
| SOURCE PLC Systems Inc. Copyright©2010 PR Newswire. All rights reserved |